These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16567686

  • 1. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis.
    Hiraki T, Sakurai J, Gobara H, Kawamoto H, Mukai T, Hase S, Iguchi T, Fujiwara H, Tajiri N, Shiratori Y, Kanazawa S.
    J Vasc Interv Radiol; 2006 Mar; 17(3):583-5. PubMed ID: 16567686
    [No Abstract] [Full Text] [Related]

  • 2. Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
    Hwang HE, Tseng HS, Liu CA, Chiou YY, Yeh YC, Chiu NC.
    J Gastroenterol Hepatol; 2017 Mar; 32(3):546. PubMed ID: 28320063
    [No Abstract] [Full Text] [Related]

  • 3. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I.
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [Abstract] [Full Text] [Related]

  • 4. Comments on "Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?".
    Lee MW.
    Radiology; 2010 Feb; 254(2):633; author reply 634. PubMed ID: 20093536
    [No Abstract] [Full Text] [Related]

  • 5. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
    Sudan D, Sudan R, Schafer D, Langnas A.
    Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
    [No Abstract] [Full Text] [Related]

  • 6. Delayed anoxic pseudolobular necrosis (terminal hepatic necrosis) after chemo-lipiodolization for hepatocellular carcinoma.
    Kozakai I, Ichida T, Yamaguchi O, Asakura H.
    Am J Gastroenterol; 1996 Jun; 91(6):1263-5. PubMed ID: 8651187
    [No Abstract] [Full Text] [Related]

  • 7. Tumor fragment impacted at the major duodenal papilla causing obstructive jaundice in a patient with hepatocellular carcinoma.
    Kobayashi N, Kirikoshi H, Higurashi T, Iida H, Mawatari H, Endo H, Nozaki Y, Yoneda K, Akiyama T, Fujita K, Yoneda M, Takahashi H, Abe Y, Inamori M, Kubota K, Saito S, Ueno N, Nakajima A.
    Gastrointest Endosc; 2008 Nov; 68(5):999-1000; discussion 1000. PubMed ID: 18640678
    [No Abstract] [Full Text] [Related]

  • 8. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Matsumoto K, Nojiri J, Takase Y, Egashira Y, Azama S, Kato A, Kitahara K, Miyazaki K, Kudo S.
    Cardiovasc Intervent Radiol; 2007 Nov; 30(3):512-4. PubMed ID: 17171304
    [Abstract] [Full Text] [Related]

  • 9. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.
    Hepatogastroenterology; 2005 Nov; 52(65):1344-6. PubMed ID: 16201070
    [Abstract] [Full Text] [Related]

  • 10. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.
    Digestion; 2007 Nov; 75(2-3):104-12. PubMed ID: 17598962
    [Abstract] [Full Text] [Related]

  • 11. Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation.
    Zheng RQ, Kudo M, Minami Y, Inui K, Chung H.
    J Gastroenterol; 2003 Nov; 38(4):406-9. PubMed ID: 12743785
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation].
    Zhou DW, Zhang ZJ, Sun W.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):786-8. PubMed ID: 15949389
    [No Abstract] [Full Text] [Related]

  • 13. [Obstructive jaundice caused by hepatocellular carcinoma].
    Nardello O, Farina GP, Cagetti M.
    Ann Ital Chir; 2005 Mar 23; 76(6):535-41. PubMed ID: 16821515
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Interventional therapy for hepatocellular carcinoma].
    Wang JH.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 23; 13(10):721-3. PubMed ID: 16248940
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Delayed cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Wu JJ, Chao M, Zhang GQ, Li B.
    Chin Med J (Engl); 2009 Apr 05; 122(7):878-80. PubMed ID: 19493407
    [No Abstract] [Full Text] [Related]

  • 20. Chemoembolization of hepatic malignancy.
    Gonsalves CF, Brown DB.
    Abdom Imaging; 2009 Apr 05; 34(5):557-65. PubMed ID: 18668189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.